132 related articles for article (PubMed ID: 20631698)
1. Developing solutions.
Padma TV
Nature; 2010 Jul; 466(7304):S16-7. PubMed ID: 20631698
[No Abstract] [Full Text] [Related]
2. HIV/AIDS. The great funding surge.
Cohen J
Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
[No Abstract] [Full Text] [Related]
3. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
Nderitu T
E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
[No Abstract] [Full Text] [Related]
4. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
5. HIV-1 viral load testing cost in developing countries: what's new?
Rouet F; Rouzioux C
Expert Rev Mol Diagn; 2007 Nov; 7(6):703-7. PubMed ID: 18020900
[No Abstract] [Full Text] [Related]
6. Cuts hamper bid to tackle AIDS.
Hayden EC
Nature; 2012 Mar; 483(7388):131-2. PubMed ID: 22398529
[No Abstract] [Full Text] [Related]
7. Called to account.
Aldhous P
Nature; 2004 Jul; 430(6996):133. PubMed ID: 15241382
[No Abstract] [Full Text] [Related]
8. HIV/AIDS. Botswana's success comes at steep cost.
Cohen J
Science; 2008 Jul; 321(5888):526-9. PubMed ID: 18653882
[No Abstract] [Full Text] [Related]
9. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
[No Abstract] [Full Text] [Related]
10. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
11. Closing the affordability gap for drugs in low-income countries.
Steinbrook R
N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
[No Abstract] [Full Text] [Related]
12. Cutbacks threaten HIV gains.
Wadman M
Nature; 2011 Dec; 480(7376):159-60. PubMed ID: 22158216
[No Abstract] [Full Text] [Related]
13. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
14. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
15. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
16. Ensuring access to essential medicines: some economic considerations.
Maskus KE
Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
[No Abstract] [Full Text] [Related]
17. 3 by 5 initiative: treating 3 million by 2005.
East Mediterr Health J; 2002 Nov; 8(6):835-7. PubMed ID: 15568463
[No Abstract] [Full Text] [Related]
18. World AIDS Day 2003.
Fauci AS
IAPAC Mon; 2003 Dec; 9(12):319. PubMed ID: 15055167
[No Abstract] [Full Text] [Related]
19. The ethics of research in developing countries.
Mullings AM
N Engl J Med; 2000 Aug; 343(5):362; author reply 363. PubMed ID: 10928890
[No Abstract] [Full Text] [Related]
20. Game changers: why did the scale-up of HIV treatment work despite weak health systems?
De Cock KM; El-Sadr WM; Ghebreyesus TA
J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S61-3. PubMed ID: 21857297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
